2021 Q2 Form 10-Q Financial Statement

#000100075321000038 Filed on August 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $1.185B $993.4M $1.229B
YoY Change 19.33% -4.79% 6.63%
Cost Of Revenue $2.021B $773.1M $995.5M
YoY Change 161.44% -11.1% 7.47%
Gross Profit $199.6M $220.2M $234.0M
YoY Change -9.4% 26.77% 3.22%
Gross Profit Margin 16.83% 22.17% 19.03%
Selling, General & Admin $314.2M $139.4M $141.2M
YoY Change 125.36% 8.82% 4.9%
% of Gross Profit 157.43% 63.29% 60.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.798M $7.900M $7.600M
YoY Change 24.03% 14.49% 13.43%
% of Gross Profit 4.91% 3.59% 3.25%
Operating Expenses $164.3M $147.3M $148.8M
YoY Change 11.59% 9.07% 5.34%
Operating Profit $35.22M $72.99M $85.22M
YoY Change -51.74% 88.5% -0.28%
Interest Expense $1.975M $2.219M $2.362M
YoY Change -11.0% 35.39% 40.51%
% of Operating Profit 5.61% 3.04% 2.77%
Other Income/Expense, Net
YoY Change
Pretax Income $34.68M $71.14M $84.74M
YoY Change -51.24% 78.36% -2.63%
Income Tax $9.530M $19.29M $22.65M
% Of Pretax Income 27.48% 27.11% 26.72%
Net Earnings $25.15M $51.85M $62.09M
YoY Change -51.49% 81.58% -18.61%
Net Earnings / Revenue 2.12% 5.22% 5.05%
Basic Earnings Per Share $0.65 $1.34 $1.59
Diluted Earnings Per Share $0.65 $1.33 $1.58
COMMON SHARES
Basic Shares Outstanding 38.59M shares 38.57M shares 38.80M shares
Diluted Shares Outstanding 38.82M shares 38.65M shares 39.07M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $490.0M $491.4M $424.2M
YoY Change -0.29% 27.27% -6.25%
Cash & Equivalents $455.4M $459.4M $404.7M
Short-Term Investments $34.60M $32.00M $19.50M
Other Short-Term Assets $47.07M $34.65M $40.43M
YoY Change 35.84% 16.3% 10.4%
Inventory
Prepaid Expenses
Receivables $595.8M $473.9M $520.7M
Other Receivables $5.128M $0.00 $0.00
Total Short-Term Assets $1.201B $1.069B $1.079B
YoY Change 12.41% 16.26% 10.12%
LONG-TERM ASSETS
Property, Plant & Equipment $219.6M $177.8M $160.3M
YoY Change 23.54% 47.12% 38.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.060M $6.151M $6.010M
YoY Change 14.78% -0.74% 8.6%
Total Long-Term Assets $526.8M $449.1M $443.1M
YoY Change 17.3% 12.89% 19.47%
TOTAL ASSETS
Total Short-Term Assets $1.201B $1.069B $1.079B
Total Long-Term Assets $526.8M $449.1M $443.1M
Total Assets $1.728B $1.518B $1.522B
YoY Change 13.86% 15.24% 12.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.063M $2.885M $6.240M
YoY Change 40.83% -55.94% -20.55%
Accrued Expenses $62.96M $60.74M $51.73M
YoY Change 3.65% 52.79% 5.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.003B $840.6M $888.5M
YoY Change 19.29% 9.19% 4.48%
LONG-TERM LIABILITIES
Long-Term Debt $369.4M $369.4M $369.4M
YoY Change 0.0% 118.06% 155.82%
Other Long-Term Liabilities $268.7M $262.4M $259.3M
YoY Change 2.41%
Total Long-Term Liabilities $638.1M $632.5M $637.3M
YoY Change 0.89% 53.43% 67.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.003B $840.6M $888.5M
Total Long-Term Liabilities $638.1M $632.5M $637.3M
Total Liabilities $1.641B $1.473B $1.526B
YoY Change 11.39% 24.62% 23.86%
SHAREHOLDERS EQUITY
Retained Earnings $627.9M $581.6M $545.3M
YoY Change 7.96% 21.89% 18.31%
Common Stock $94.95M $55.34M $46.88M
YoY Change 71.58% 33.14% 36.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $635.6M $592.3M $595.5M
YoY Change 7.31% 54.32% 58.33%
Treasury Stock Shares
Shareholders Equity $87.26M $44.64M -$3.310M
YoY Change
Total Liabilities & Shareholders Equity $1.728B $1.518B $1.522B
YoY Change 13.86% 15.24% 12.69%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $25.15M $51.85M $62.09M
YoY Change -51.49% 81.58% -18.61%
Depreciation, Depletion And Amortization $9.798M $7.900M $7.600M
YoY Change 24.03% 14.49% 13.43%
Cash From Operating Activities $4.995M $91.10M $23.79M
YoY Change -94.52% -301.1% -79.79%
INVESTING ACTIVITIES
Capital Expenditures -$8.608M -$23.90M $15.63M
YoY Change -63.98% 106.03% 178.62%
Acquisitions
YoY Change
Other Investing Activities -$522.0K -$12.60M $15.30M
YoY Change -95.86% 72.6% 109.59%
Cash From Investing Activities -$9.130M -$36.50M -$314.0K
YoY Change -74.99% 93.12% -118.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.94M -13.70M $25.60M
YoY Change 82.02% -349.09% -163.47%
NET CHANGE
Cash From Operating Activities 4.995M 91.10M $23.79M
Cash From Investing Activities -9.130M -36.50M -$314.0K
Cash From Financing Activities -24.94M -13.70M $25.60M
Net Change In Cash -29.07M 40.90M $49.08M
YoY Change -171.08% -169.68% -37.94%
FREE CASH FLOW
Cash From Operating Activities $4.995M $91.10M $23.79M
Capital Expenditures -$8.608M -$23.90M $15.63M
Free Cash Flow $13.60M $115.0M $8.162M
YoY Change -88.17% -441.25% -92.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
INSPERITY, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001000753
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38602629 shares
nsp Time Period Incurred Claims Expected To Be Paid Included In Deposits
TimePeriodIncurredClaimsExpectedToBePaidIncludedInDeposits
Greater than 1 year
nsp Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Long Term Liabilities
TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInLongTermLiabilities
Greater than 1 year
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13998
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0479645
dei Entity Address Address Line1
EntityAddressAddressLine1
19001 Crescent Springs Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Kingwood,
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77339
dei City Area Code
CityAreaCode
281
dei Local Phone Number
LocalPhoneNumber
358-8986
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38602629 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
455387000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554846000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46128000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
45522000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
34597000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
34529000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
595836000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
392746000 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
17143000 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
10164000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
47070000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39461000 USD
CY2021Q2 us-gaap Nontrade Receivables
NontradeReceivables
5128000 USD
CY2020Q4 us-gaap Nontrade Receivables
NontradeReceivables
0 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1201289000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1077268000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219611000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
216256000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66463000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60663000 USD
CY2021Q2 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2020Q4 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2021Q2 nsp Deposits Health Insurance
DepositsHealthInsurance
7900000 USD
CY2020Q4 nsp Deposits Health Insurance
DepositsHealthInsurance
7900000 USD
CY2021Q2 nsp Deposits Workers Compensation
DepositsWorkersCompensation
203612000 USD
CY2020Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
186331000 USD
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12707000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12707000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
442000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9603000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7060000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4548000 USD
CY2021Q2 us-gaap Assets
Assets
1728084000 USD
CY2020Q4 us-gaap Assets
Assets
1584276000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4063000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6203000 USD
CY2021Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
262975000 USD
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
377960000 USD
CY2021Q2 nsp Accrued Worksite Employee Payroll Costs
AccruedWorksiteEmployeePayrollCosts
529881000 USD
CY2020Q4 nsp Accrued Worksite Employee Payroll Costs
AccruedWorksiteEmployeePayrollCosts
334836000 USD
CY2021Q2 nsp Accrued Health Insurance Costs
AccruedHealthInsuranceCosts
29064000 USD
CY2020Q4 nsp Accrued Health Insurance Costs
AccruedHealthInsuranceCosts
32685000 USD
CY2021Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
49845000 USD
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
48186000 USD
CY2021Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
63901000 USD
CY2020Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
44277000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62960000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60777000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1002689000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
904924000 USD
CY2021Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
192703000 USD
CY2020Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
195239000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
69736000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64289000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6294000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6292000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
638133000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
635220000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
555000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
555000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
94396000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95528000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
635627000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
626984000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
627938000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
575033000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87262000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44132000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1728084000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1584276000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1185371000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993366000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2472206000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2222849000 USD
CY2021Q2 nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
985817000 USD
CY2020Q2 nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
773117000 USD
nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
2021207000 USD
nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
1768578000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
199554000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
220249000 USD
us-gaap Gross Profit
GrossProfit
450999000 USD
us-gaap Gross Profit
GrossProfit
454271000 USD
CY2021Q2 nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
94362000 USD
CY2020Q2 nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
90710000 USD
nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
197437000 USD
nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
177211000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13781000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10694000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25603000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17246000 USD
CY2021Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
8251000 USD
CY2020Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
7475000 USD
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
15970000 USD
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
15935000 USD
CY2021Q2 us-gaap Advertising Expense
AdvertisingExpense
8975000 USD
CY2020Q2 us-gaap Advertising Expense
AdvertisingExpense
5720000 USD
us-gaap Advertising Expense
AdvertisingExpense
14297000 USD
us-gaap Advertising Expense
AdvertisingExpense
10553000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29211000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24755000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60847000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59608000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9751000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7908000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17798000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15510000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
164331000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
147262000 USD
us-gaap Operating Expenses
OperatingExpenses
331952000 USD
us-gaap Operating Expenses
OperatingExpenses
296063000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
35223000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
72987000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
119047000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
158208000 USD
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
1436000 USD
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
369000 USD
us-gaap Interest Income Other
InterestIncomeOther
1979000 USD
us-gaap Interest Income Other
InterestIncomeOther
2248000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
1975000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
2219000 USD
us-gaap Interest Expense
InterestExpense
3574000 USD
us-gaap Interest Expense
InterestExpense
4581000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34684000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
71137000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
117452000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
155875000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9530000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19286000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30376000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41932000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
25154000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
51851000 USD
us-gaap Net Income Loss
NetIncomeLoss
87076000 USD
us-gaap Net Income Loss
NetIncomeLoss
113943000 USD
CY2021Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
37000 USD
CY2020Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
276000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
193000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
724000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25117000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51575000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
86883000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
113219000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
CY2021Q2 nsp Gross Billings
GrossBillings
7637851000 USD
CY2020Q2 nsp Gross Billings
GrossBillings
6355683000 USD
nsp Gross Billings
GrossBillings
15688273000 USD
nsp Gross Billings
GrossBillings
13792437000 USD
CY2021Q2 nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
6452480000 USD
CY2020Q2 nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
5362317000 USD
nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
13216067000 USD
nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
11569588000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1185371000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993366000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2472206000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2222849000 USD
us-gaap Net Income Loss
NetIncomeLoss
87076000 USD
us-gaap Net Income Loss
NetIncomeLoss
113943000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17798000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15510000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25603000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17246000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9161000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4668000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
203559000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8156000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6979000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13076000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7609000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-8842000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-5407000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-6979000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2140000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1680000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-114985000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-57756000 USD
nsp Increase Decreasein Wse Epayrollexpense
IncreaseDecreaseinWSEEpayrollexpense
195045000 USD
nsp Increase Decreasein Wse Epayrollexpense
IncreaseDecreaseinWSEEpayrollexpense
7209000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
-3621000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
8534000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-877000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-357000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
13697000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-19273000 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-7022000 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
32228000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-80081000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
918000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6995000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
114861000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
30862000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
25438000 USD
nsp Marketable Securities Proceeds From Dispositions
MarketableSecuritiesProceedsFromDispositions
0 USD
nsp Marketable Securities Proceeds From Dispositions
MarketableSecuritiesProceedsFromDispositions
484000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30340000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27625000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20708000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39466000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21230000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36795000 USD
nsp Treasury Stock Acquired
TreasuryStockAcquired
38536000 USD
nsp Treasury Stock Acquired
TreasuryStockAcquired
61230000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
32828000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
31074000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
100000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4027000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4247000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67337000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11943000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-81572000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
90009000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
786699000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
592550000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
705127000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
682559000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554846000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
367342000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
45522000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
49295000 USD
CY2020Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
186331000 USD
CY2019Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
175913000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
786699000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
592550000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
455387000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
459399000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46128000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
45216000 USD
CY2021Q2 nsp Deposits Workers Compensation
DepositsWorkersCompensation
203612000 USD
CY2020Q2 nsp Deposits Workers Compensation
DepositsWorkersCompensation
177944000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
705127000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
682559000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15047000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10196000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44132000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
38536000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25603000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
240000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1582000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
32828000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000 USD
us-gaap Net Income Loss
NetIncomeLoss
87076000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87262000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4079000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
61230000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17246000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1605000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
31074000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
69000 USD
us-gaap Net Income Loss
NetIncomeLoss
113943000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
44638000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
73644000 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8850000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13781000 USD
CY2021Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-900000 USD
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17367000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
25154000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87262000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-3310000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27000 USD
nsp Number Of Days In Advance Of Beginning Of Reporting Quarter Carrier Establishes Cash Funding Rates
NumberOfDaysInAdvanceOfBeginningOfReportingQuarterCarrierEstablishesCashFundingRates
P90D
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10694000 USD
CY2020Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-963000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15517000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-16000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
51851000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
44638000 USD
CY2021Q2 nsp Percentageofourhealthinsurancecoverageprovidedby United
PercentageofourhealthinsurancecoverageprovidedbyUnited
0.87
CY2021Q2 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000.0 USD
CY2021Q2 nsp Required Deposit For Health Care Costs
RequiredDepositForHealthCareCosts
6500000 USD
CY2021Q2 nsp Prepaid Health Insurance Current And Noncurrent
PrepaidHealthInsuranceCurrentAndNoncurrent
600000 USD
CY2021Q2 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000.0 USD
CY2021Q2 nsp Prepaid Health Insurance Current
PrepaidHealthInsuranceCurrent
-8400000 USD
CY2021Q2 nsp Premiums Owed To United
PremiumsOwedToUnited
14500000 USD
CY2021Q2 nsp Benefits Costs Incurred Reduced Relatedto Runoff
BenefitsCostsIncurredReducedRelatedtoRunoff
5700000 USD
CY2020Q2 nsp Benefits Costs Incurred Reduced Relatedto Runoff
BenefitsCostsIncurredReducedRelatedtoRunoff
-3000000.0 USD
CY2021Q2 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2021Q2 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2021Q2 nsp Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year
WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear
6000000 USD
CY2021Q2 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
CY2019Q4 nsp Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year
WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear
6000000 USD
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
nsp Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses
DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses
23000000.0 USD
nsp Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses
DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses
22200000 USD
nsp Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period
USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod
0.005
nsp Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period
USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod
0.008
CY2020Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments
240761000 USD
CY2019Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments
242904000 USD
nsp Workers Compensation Expense
WorkersCompensationExpense
20559000 USD
nsp Workers Compensation Expense
WorkersCompensationExpense
21888000 USD
nsp Workers Compensation Discount Changed During Period
WorkersCompensationDiscountChangedDuringPeriod
407000 USD
nsp Workers Compensation Discount Changed During Period
WorkersCompensationDiscountChangedDuringPeriod
223000 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
22904000 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
22298000 USD
CY2021Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
238823000 USD
CY2020Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
242717000 USD
CY2021Q2 nsp Workers Compensation Liability Net Of Admin Fees Current
WorkersCompensationLiabilityNetOfAdminFeesCurrent
46120000 USD
CY2020Q2 nsp Workers Compensation Liability Net Of Admin Fees Current
WorkersCompensationLiabilityNetOfAdminFeesCurrent
45216000 USD
CY2021Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
192703000 USD
CY2020Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
197501000 USD
CY2021Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
238823000 USD
CY2020Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
242717000 USD
CY2021Q2 nsp Workers Compensation Administrative Fees Accrued
WorkersCompensationAdministrativeFeesAccrued
3700000 USD
nsp Undiscounted Accrued Workers Compensation Costs
UndiscountedAccruedWorkersCompensationCosts
254800000 USD
nsp Undiscounted Accrued Workers Compensation Costs
UndiscountedAccruedWorkersCompensationCosts
261400000 USD
nsp Time Period Incurred Claims Expected To Be Paid Recorded As Restricted
TimePeriodIncurredClaimsExpectedToBePaidRecordedAsRestricted
P1Y
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46100000 USD
CY2021Q2 nsp Deposits Workers Compensation
DepositsWorkersCompensation
203600000 USD
nsp Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Short Term Liabilities
TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInShortTermLiabilities
P1Y
CY2021Q2 nsp Unbilled
Unbilled
585400000 USD
CY2020Q4 nsp Unbilled
Unbilled
380800000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1185371000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993366000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2472206000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2222849000 USD
CY2021Q2 nsp Money Market Funds Overnight Holdings At Carrying Value
MoneyMarketFundsOvernightHoldingsAtCarryingValue
387027000 USD
CY2020Q4 nsp Money Market Funds Overnight Holdings At Carrying Value
MoneyMarketFundsOvernightHoldingsAtCarryingValue
503221000 USD
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
82584000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
82521000 USD
CY2021Q2 us-gaap Cash
Cash
31931000 USD
CY2020Q4 us-gaap Cash
Cash
33692000 USD
CY2021Q2 srt Drafts Payable
DraftsPayable
11558000 USD
CY2020Q4 srt Drafts Payable
DraftsPayable
30059000 USD
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
489984000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
589375000 USD
CY2021Q2 nsp Payroll Withholdings Included In Cash Balance
PayrollWithholdingsIncludedInCashBalance
226700000 USD
CY2020Q4 nsp Payroll Withholdings Included In Cash Balance
PayrollWithholdingsIncludedInCashBalance
342000000.0 USD
CY2021Q2 nsp Client Prepayments Included In Cash Balance
ClientPrepaymentsIncludedInCashBalance
-50400000 USD
CY2020Q4 nsp Client Prepayments Included In Cash Balance
ClientPrepaymentsIncludedInCashBalance
-35300000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
435014000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
551213000 USD
CY2021Q2 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
12318000 USD
CY2020Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
10531000 USD
CY2021Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
22279000 USD
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
23998000 USD
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
469611000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
585742000 USD
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
34599000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
1000 USD
CY2021Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000.0 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
3000 USD
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
34597000 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
34524000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
9000 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
4000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
34529000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
29469000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
29468000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5130000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5129000 USD
CY2021Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
500000000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
550000000 USD
nsp Percentage Of Subsidiary Stock Securing Debt
PercentageOfSubsidiaryStockSecuringDebt
0.65
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2021Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
129600000 USD
CY2021Q2 nsp Applicable Margin Federal Funds Rate
ApplicableMarginFederalFundsRate
0.0050
CY2021Q2 nsp Applicable Margin30 Day Libor
ApplicableMargin30DayLibor
0.0200
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.019
nsp Aggregatenumberofsharesrepurchasedduringtheperiod
Aggregatenumberofsharesrepurchasedduringtheperiod
437903 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
147281 shares
CY2021Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
980856 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
290622 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
32800000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
31100000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
25154000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
51851000 USD
us-gaap Net Income Loss
NetIncomeLoss
87076000 USD
us-gaap Net Income Loss
NetIncomeLoss
113943000 USD
CY2021Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
37000 USD
CY2020Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
276000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
193000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
724000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25117000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51575000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
86883000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
113219000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38591000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38567000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38410000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38684000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
232000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
79000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
427000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
173000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38823000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38646000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38837000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38857000 shares
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0 USD

Files In Submission

Name View Source Status
0001000753-21-000038-index-headers.html Edgar Link pending
0001000753-21-000038-index.html Edgar Link pending
0001000753-21-000038.txt Edgar Link pending
0001000753-21-000038-xbrl.zip Edgar Link pending
a06302021-nspex311.htm Edgar Link pending
a06302021-nspex312.htm Edgar Link pending
a06302021-nspex321.htm Edgar Link pending
a06302021-nspex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nsp-20210630.htm Edgar Link pending
nsp-20210630.xsd Edgar Link pending
nsp-20210630_cal.xml Edgar Link unprocessable
nsp-20210630_def.xml Edgar Link unprocessable
nsp-20210630_g1.jpg Edgar Link pending
nsp-20210630_g10.jpg Edgar Link pending
nsp-20210630_g11.jpg Edgar Link pending
nsp-20210630_g2.jpg Edgar Link pending
nsp-20210630_g3.jpg Edgar Link pending
nsp-20210630_g4.jpg Edgar Link pending
nsp-20210630_g5.jpg Edgar Link pending
nsp-20210630_g6.jpg Edgar Link pending
nsp-20210630_g7.jpg Edgar Link pending
nsp-20210630_g8.jpg Edgar Link pending
nsp-20210630_g9.jpg Edgar Link pending
nsp-20210630_htm.xml Edgar Link completed
nsp-20210630_lab.xml Edgar Link unprocessable
nsp-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending